Epigenetics in Alzheimer’s Disease: A Critical Overview
Open Access
- 29 May 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 5970
Abstract
Epigenetic modifications have been implicated in a number of complex diseases as well as being a hallmark of organismal aging. Several reports have indicated an involvement of these changes in Alzheimer’s disease (AD) risk and progression, most likely contributing to the dysregulation of AD-related gene expression measured by DNA methylation studies. Given that DNA methylation is tissue-specific and that AD is a brain disorder, the limitation of these studies is the ability to identify clinically useful biomarkers in a proxy tissue, reflective of the tissue of interest, that would be less invasive, more cost-effective, and easily obtainable. The age-related DNA methylation changes have also been used to develop different generations of epigenetic clocks devoted to measuring the aging in different tissues that sometimes suggests an age acceleration in AD patients. This review critically discusses epigenetic changes and aging measures as potential biomarkers for AD detection, prognosis, and progression. Given that epigenetic alterations are chemically reversible, treatments aiming at reversing these modifications will be also discussed as promising therapeutic strategies for AD.Keywords
This publication has 132 references indexed in Scilit:
- MicroRNA‐340‐5p increases telomere length by targeting telomere protein POT1 to improve Alzheimer's disease in miceCell Biology International, 2021
- Association of Epigenetic Metrics of Biological Age With Cortical ThicknessJAMA Network Open, 2020
- DNA methylation in APOE: The relationship with Alzheimer's and with cardiovascular healthAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2020
- Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related DiseasesCellular and Molecular Neurobiology, 2019
- An investigation of microRNA‐103 and microRNA‐107 as potential blood‐based biomarkers for disease risk and progression of Alzheimer's diseaseJournal of Clinical Laboratory Analysis, 2019
- Mitochondrial DNA: Epigenetics and environmentEnvironmental and Molecular Mutagenesis, 2019
- Prediction of brain age suggests accelerated atrophy after traumatic brain injuryAnnals of Neurology, 2015
- The many glia of a tiny nematode: studying glial diversity using Caenorhabditis elegansWIREs Developmental Biology, 2015
- Association of Brain DNA Methylation inSORL1,ABCA7,HLA-DRB5,SLC24A4, andBIN1With Pathological Diagnosis of Alzheimer DiseaseJAMA Neurology, 2015
- miR‐206 regulates brain‐derived neurotrophic factor in Alzheimer disease modelAnnals of Neurology, 2012